Inhibitory potencies of 1,4-dihydropyridine calcium antagonists to P-glycoprotein-mediated transport: comparison with the effects on CYP3A4.
- 1 January 2000
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 17 (10) , 1189-1197
- https://doi.org/10.1023/a:1007568811691
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Interaction of Docetaxel (“Taxotere”) with Human P‐GlycoproteinJapanese Journal of Cancer Research, 1999
- Cellular Pharmacokinetic Aspects of Reversal Effect of Itraconazole on P-Glycoprotein-Mediated Resistance of Anticancer Drugs.Biological & Pharmaceutical Bulletin, 1999
- Effects of Intestinal CYP3A4 and P-Glycoprotein on Oral Drug Absorption—Theoretical ApproachPharmaceutical Research, 1999
- Interrelationship Between Substrates and Inhibitors of Human CYP3A and P-GlycoproteinPharmaceutical Research, 1999
- Inhibitory Effects of a Cyclosporin Derivative, SDZ PSC 833, on Transport of Doxorubicin and Vinblastine via Human P-GlycoproteinJapanese Journal of Cancer Research, 1998
- The CYP2 family: models, mutants and interactionsXenobiotica, 1998
- Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).1992
- Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoproteinBiochemical Pharmacology, 1992
- Non-interaction between nifedipine and digoxin.1986
- INTERACTION BETWEEN DIGOXIN AND THE CALCIUM-ANTAGONISTS NICARDIPINE AND TIAPAMIL1983